# Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308

> **NCT02001389** · PHASE1 · COMPLETED · sponsor: **FORUM Pharmaceuticals Inc** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** EVP-6308

## Key facts

- **NCT ID:** NCT02001389
- **Lead sponsor:** FORUM Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-06
- **Final completion:** —
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001389, "Study of EVP-6308 to Assess the Dose- and Concentration-dependent Displacement of [18F]MNI-659 by EVP-6308". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02001389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*